276
Views
24
CrossRef citations to date
0
Altmetric
Review

Targeting stem cells in the realm of drug-resistant breast cancer

, &
Pages 115-135 | Published online: 07 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shinichi Umeda, Mitsuro Kanda & Yasuhiro Kodera. (2019) Recent advances in molecular biomarkers for patients with hepatocellular carcinoma. Expert Review of Molecular Diagnostics 19:8, pages 725-738.
Read now

Articles from other publishers (23)

Sumit K. Mishra, Ajit C. Dhadve, Arijit Mal, B. Pradeep K. Reddy, Arti Hole, Murali Krishna Chilakapati, Pritha Ray, Rohit Srivastava & Abhijit De. (2022) Photothermal therapy (PTT) is an effective treatment measure against solid tumors which fails to respond conventional chemo/radiation therapies in clinic. Biomaterials Advances 143, pages 213153.
Crossref
Patricia Cámara-Sánchez, Zamira V. Díaz-Riascos, Natalia García-Aranda, Petra Gener, Joaquin Seras-Franzoso, Micaela Giani-Alonso, Miriam Royo, Esther Vázquez, Simó SchwartzJr.Jr. & Ibane Abasolo. (2022) Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide. International Journal of Molecular Sciences 23:19, pages 11760.
Crossref
Pranay Dey, Mansi Joshi, Aaiyas Mujawar, Renu Malhotra & Abhijit De. (2022) Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer. Cellular Oncology 45:5, pages 873-891.
Crossref
O.P. Lukashova, О.М. Bilyy, V.S. Pakhomov, S.V. Shutov, О.V. Slobodianyuk, І.V. Lepekha & І.М. Teslenko. (2022) The effect of neoadjuvant chemotherapy on the structural and functional state of tumor cells in the secondary edematous form of breast cancer. Український радіологічний та онкологічний журнал 30:2, pages 72-87.
Crossref
Franklyn De Silva & Jane Alcorn. (2022) A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer. Cancers 14:12, pages 2954.
Crossref
Nitin T. Telang. (2022) The Divergent Effects of Ovarian Steroid Hormones in the MCF-7 Model for Luminal A Breast Cancer: Mechanistic Leads for Therapy. International Journal of Molecular Sciences 23:9, pages 4800.
Crossref
Forough Shams, Ali Golchin, Arezo Azari, Leila Mohammadi Amirabad, Fateme Zarein, Atiyeh Khosravi & Abdolreza Ardeshirylajimi. (2021) Nanotechnology-based products for cancer immunotherapy. Molecular Biology Reports 49:2, pages 1389-1412.
Crossref
Yoser Al Rawi, Saima Shakil Malik & Nosheen Masood. 2022. Breast Cancer: From Bench to Personalized Medicine. Breast Cancer: From Bench to Personalized Medicine 403 417 .
Priya Gupta, Yub Raj Neupane, Suhel Parvez & Kanchan Kohli. (2021) Recent advances in targeted nanotherapeutic approaches for breast cancer management. Nanomedicine 16:29, pages 2605-2631.
Crossref
Michelle van der Merwe, Gustav van Niekerk, Carla Fourie, Manisha du Plessis & Anna-Mart Engelbrecht. (2021) The impact of mitochondria on cancer treatment resistance. Cellular Oncology 44:5, pages 983-995.
Crossref
Chanjuan Zheng, Shichao Yan, Lu Lu, Hui Yao, Guangchun He, Sisi Chen, Ying Li, Xiaojun Peng, Zhongyi Cheng, Mi Wu, Qiuting Zhang, Guifei Li, Shujun Fu & Xiyun Deng. (2021) Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins. Frontiers in Oncology 11.
Crossref
Qinghui Zheng, Mengdi Zhang, Fangfang Zhou, Long Zhang & Xuli Meng. (2021) The Breast Cancer Stem Cells Traits and Drug Resistance. Frontiers in Pharmacology 11.
Crossref
Prashant S. Kharkar. (2020) Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives. Journal of Medicinal Chemistry 63:24, pages 15279-15307.
Crossref
Ilaria Plantamura, Alessandra Cataldo, Giulia Cosentino & Marilena V. Iorio. (2020) miR-205 in Breast Cancer: State of the Art. International Journal of Molecular Sciences 22:1, pages 27.
Crossref
Hui Shi, Luping Zhao, Xinlin Guo, Runping Fang, Hui Zhang, Guanjun Dong, Jia Fu, Fenglian Yan, Junfeng Zhang, Zhaochen Ning, Qun Ma, Zhihua Li, Chunxia Li, Jun Dai, Chuanping Si & Huabao Xiong. (2020) Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. International Journal of Molecular Sciences 21:17, pages 6357.
Crossref
Susana Fiorentino, Claudia Urueña, Paola Lasso, Karol Prieto & Alfonso Barreto. (2020) Phyto-Immunotherapy, a Complementary Therapeutic Option to Decrease Metastasis and Attack Breast Cancer Stem Cells. Frontiers in Oncology 10.
Crossref
Nitin Telang. (2020) Natural phytochemicals as testable therapeutic alternatives for HER‑2‑enriched breast cancer (Review). World Academy of Sciences Journal.
Crossref
José Manuel García-Heredia & Amancio Carnero. (2020) Role of Mitochondria in Cancer Stem Cell Resistance. Cells 9:7, pages 1693.
Crossref
Panpan Wang, Dan Song, Danhong Wan, Lingyu Li, Wenhui Mei, Xiaoyun Li, Li Han, Xiaofeng Zhu, Li Yang, Yu Cai & Ronghua Zhang. (2020) Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways. PeerJ 8, pages e9281.
Crossref
Mireia Pesarrodona, Laura Sánchez-García, Joaquin Seras-Franzoso, Alejandro Sánchez-Chardi, Ricardo Baltá-Foix, Patricia Cámara-Sánchez, Petra Gener, José Juan Jara, Daniel Pulido, Naroa Serna, Simó SchwartzJr.Jr., Miriam Royo, Antonio Villaverde, Ibane Abasolo & Esther Vazquez. (2019) Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells. ACS Applied Materials & Interfaces 12:5, pages 5381-5388.
Crossref
Ralf Hass, Juliane von der Ohe & Hendrik Ungefroren. (2019) Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation. Cancers 11:10, pages 1432.
Crossref
Yue Pan, Yunqiu Zhang, Qing Chen, Xufeng Tao, Jianzhou Liu & Gary Guishan Xiao. (2019) CTAB Enhances Chemo-Sensitivity Through Activation of AMPK Signaling Cascades in Breast Cancer. Frontiers in Pharmacology 10.
Crossref
David Rodriguez, Marc Ramkairsingh, Xiaozeng Lin, Anil Kapoor, Pierre Major & Damu Tang. (2019) The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer. Cancers 11:7, pages 1028.
Crossref